Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05541601

Prospective Cohort for Early Detection of Liver Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

This study aims to recruit 3000 people with liver cirrhosis into a Prospective cohort for early detection of Liver cancer - the Pearl cohort. The study team believe that using a combination of novel tests may improve the detection of early Hepatocellular Carcinoma (HCC).

Detailed description

During a four-year follow-up period, around 100 Pearl patients are expected to be diagnosed with HCC. Blood, urine, clinical and imaging data will be collected over the follow up period. The samples will be used to identify a range of tests (including genetic, protein and other biomarkers), which along with the clinical data will hopefully identify those most at risk of developing HCC, and to identify HCC at the earliest possible time points.

Conditions

Interventions

TypeNameDescription
OTHERBlood and Urine samplesThe samples will be used to identify a range of tests (including genetic, protein and other biomarkers), which along with the clinical data will hopefully identify those most at risk of developing HCC, and to identify HCC at the earliest possible time points.

Timeline

Start date
2022-02-23
Primary completion
2037-07-01
Completion
2037-07-01
First posted
2022-09-15
Last updated
2022-09-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05541601. Inclusion in this directory is not an endorsement.